Exploring compositional and predicted functional alterations of gut microbiota in H. pylori infection
Noha Salah Soliman1, May Sherif Soliman2, Heba Sherif Abdel Aziz2
1Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt. noha.salah@kasralainy.edu.eg.
Abstract:
H. pylori infection is prevalent worldwide having detrimental effects on the gastrointestinal tract. H. pylori has been linked to compositional variations in gastric microbiota, with insufficient knowledge on extended effect to intestinal microbiota. Moreover, functional potentials of gut microbiota remain underexplored. Aim We sought to investigate the compositional and functional shifts in gut microbiota associated with H. pylori infection. Total 54 stool samples were obtained from H. pylori infected patients tested positive for stool antigen (n = 31) compared to control group (n = 23). All samples were subjected to 16SrRNA next-generation sequencing. By comparison with the control group, the H. pylori-positive group displayed relatively higher mean relative abundance (RA) of phyla of Bacteroidetes (43.59%) and Proteobacteria (8.36%), mainly genera of Bacteroides (22.5%) and Prevotella (13.48%) and species of Bacteroides vulgatus (7%) and E. coli (4%). Other low abundant clinically relevant taxa were more enriched in H. pylori-positive group than controls such as Desulfovibrio, Enterococcaceae, Rikenellacae, and Akkermansia. H. pylori-positive group showed distinctive representaion of Prevotella species (PAC001042_s), Citrobacter and Howardella,, while Blautia genus was exclusively identified in the control group. Both study groups showed comparable microbiota diversities with no significant difference. H. pylori-positive group revealed higher abundance of MAPK signaling functional pathways (FDR = 0.046), along with Cell cycle and Ariginine and proloine pathways (FDR = 0.05) compared to the controls. Our findings inferred compositional and functional alterations in H. pylori-associated gut microbiota that may play role in gut inflammation and malignant transformation observed in H. pylori infection.
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...


